How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI
Medical Information (MI), Pharmacovigilance (PV) and Regulatory Affairs (RA) each play distinct but deeply interconnected roles in ensuring therapeutics are safe, accurately labeled and compliantly communicated to healthcare professionals and patients. Yet in practice the boundaries between these functions are rarely clean; a safety signal surfaced through an MI inquiry can trigger a PV investigation, which in turn may prompt a label update, a Risk Management Plan revision and coordinated external communications. When these handoffs work well, they are nearly invisible. When they break down, the consequences can be significant.
This on‑demand panel brings together experienced cross‑functional practitioners to examine how MI, PV and RA collaborate across the full product lifecycle, from the moment an inquiry arrives to the resolution of a safety crisis. Panelists walk through the critical touchpoints that define effective collaboration: how potential adverse events are identified and escalated from MI to PV; how PV investigates and determines signal significance; how RA maintains labeling consistency in response to evolving safety data; and how all three functions align on response development for complex or sensitive inquiries, including off‑label scenarios.
The session also addresses the realities of cross‑functional work, including common communication and decision‑making pitfalls and practical steps organizations can take to avoid them. Particular attention is given to crisis and escalation management, how teams can build structures, governance and relationships to respond swiftly and cohesively when urgent safety situations arise.
Looking ahead, the panel explores how the roles of MI, PV and RA are evolving in an increasingly data‑rich environment. Panelists offer a candid discussion of opportunities and risks associated with AI and automation: how these tools can strengthen signal detection, streamline cross‑functional workflows and improve consistency across labeling and communications and what governance frameworks are needed to ensure responsible deployment.
On‑demand panel with real‑world case examples and practical guidance, available to watch anytime.
